Regulation & Policy
FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder
Summary: The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.
Adults 21+. WINDBAR does not sell nicotine products on this site. Compliance statement.